Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma
Journal of Cancer · 2026-05-29 · 17 (6) · 1134-1154
DOI: 10.7150/jca.134792 ↗At a glance
Journal article in Journal of Cancer, published on 2026-05-29. Written by Zheng Shao and 9 co-authors. Institution: School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China. The full text is freely available in PubMed Central.
Abstract (original language)
Aucun résumé disponible.
Subjects
Author keywords
Authors and institutions
- School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
- School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, 523808, China.
- Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
- Department of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Cite
APA
Shao, Z., Situ, Y., Lai, B., Xu, Y., Chen, J., Deng, L., Xu, Q., Liang, M., Liang, Z., & Xie, Z. (2026). Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma. Journal of Cancer, 17(6), 1134-1154. https://doi.org/10.7150/jca.134792
Vancouver
Shao Z, Situ Y, Lai B, Xu Y, Chen J, Deng L, et al. Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma. Journal of Cancer. 2026;17(6):1134-1154. doi:10.7150/jca.134792
BibTeX
@article{Shao2026,
author = {Shao, Zheng and Situ, YongLi and Lai, Bairu and Xu, Ying and Chen, Jv and Deng, Li and Xu, QinYing and Liang, Meng and Liang, Zhu and Xie, ZhanQiang},
title = {Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {6},
pages = {1134--1154},
doi = {10.7150/jca.134792}
}
EUVIMED